Tower Research Capital LLC TRC grew its stake in Relx Plc (NYSE:RELX - Free Report) by 361.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 50,986 shares of the technology company's stock after purchasing an additional 39,935 shares during the period. Tower Research Capital LLC TRC's holdings in Relx were worth $2,316,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Virtu Financial LLC acquired a new position in shares of Relx in the third quarter valued at $223,000. Wilmington Savings Fund Society FSB acquired a new position in shares of Relx in the 3rd quarter valued at $125,000. Peapack Gladstone Financial Corp lifted its holdings in shares of Relx by 5.7% during the 3rd quarter. Peapack Gladstone Financial Corp now owns 4,924 shares of the technology company's stock worth $234,000 after acquiring an additional 267 shares during the period. Franklin Resources Inc. boosted its position in shares of Relx by 3.3% during the 3rd quarter. Franklin Resources Inc. now owns 18,429 shares of the technology company's stock valued at $873,000 after acquiring an additional 588 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in Relx by 14.6% in the third quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company's stock valued at $39,225,000 after acquiring an additional 104,999 shares during the period. Institutional investors own 15.02% of the company's stock.
Relx Price Performance
Shares of NYSE:RELX traded down $0.37 during midday trading on Monday, reaching $53.18. The company's stock had a trading volume of 180,251 shares, compared to its average volume of 675,890. The business's fifty day simple moving average is $49.53 and its 200-day simple moving average is $48.25. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. Relx Plc has a fifty-two week low of $40.77 and a fifty-two week high of $53.56. The company has a market capitalization of $98.42 billion, a P/E ratio of 28.59, a P/E/G ratio of 2.73 and a beta of 0.84.
Relx Increases Dividend
The business also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be given a $0.5586 dividend. This represents a yield of 1.6%. The ex-dividend date is Friday, May 9th. This is a boost from Relx's previous semi-annual dividend of $0.23. Relx's dividend payout ratio (DPR) is presently 59.68%.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on RELX. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. StockNews.com lowered Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. The Goldman Sachs Group assumed coverage on shares of Relx in a research report on Wednesday, March 26th. They set a "buy" rating for the company. Finally, Redburn Atlantic began coverage on shares of Relx in a research report on Wednesday, January 8th. They issued a "buy" rating on the stock. One research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Relx presently has an average rating of "Buy".
Read Our Latest Research Report on RELX
Relx Company Profile
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Further Reading
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
